<DOC>
	<DOCNO>NCT00538629</DOCNO>
	<brief_summary>Investigation impact Zeldox metabolic parameter patient bipolar disorder schizophrenia impact treatment quality life .</brief_summary>
	<brief_title>Noninterventional Study Bipolar Disorder Schizophrenia With Zeldox</brief_title>
	<detailed_description>Observational survey consecutive patient sampling .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Manic mixed episode moderate severity patient type I II bipolar disorder schizophrenia ; either first diagnose repeat episode . Patients history hypersensitivity Ziprasidone . Previous insufficiency ZiprasidoneÂ´s treatment . The break previous therapeutic condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>